Myomo (MYO) Depreciation and Depletion (2016 - 2025)
Myomo (MYO) reported Depreciation and Depletion of $246851.0 for Q3 2025, up 407.06% on a YoY basis from $48683.0 in Q3 2024, and up 29.38% quarter-over-quarter from $190798.0 in Q2 2025.
Myomo (MYO) Depreciation and Depletion (2016 - 2025) Analysis & Trends
Myomo has reported Depreciation and Depletion for 10 years, with the latest figure at $246851.0 in Q3 2025.
- For the quarter ending Q3 2025, Depreciation and Depletion rose 407.06% year-over-year to $246851.0; the trailing twelve-month figure through Sep 2025 stood at $687655.0 (up 383.46% YoY), and the FY2024 full-year result was $205910.0, up 25.32% from the prior year.
- Depreciation and Depletion for Q3 2025 stood at $246851.0, up from $190798.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $246851.0 in Q3 2025, with the low at $23313.0 in Q1 2021.
- Historically, Depreciation and Depletion has averaged $68689.5 across 5 years, with a median of $48683.0 in 2024.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion tumbled 43.15% — and 2025, when it jumped 433.74%.
- Myomo's Depreciation and Depletion stood at $50757.0 in 2021, then dropped by 3.35% to $49057.0 in 2022, then plunged by 43.15% to $27890.0 in 2023, then jumped by 228.3% to $91564.0 in 2024, then jumped by 169.59% to $246851.0 in 2025.
- The last three Depreciation and Depletion figures came in at $246851.0 (Q3 2025), $190798.0 (Q2 2025), and $158442.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,851.00 |
| Sep 30, 2025 | 246,851.00 |
| Jun 30, 2025 | 190,798.00 |
| Jun 30, 2025 | 190,798.00 |
| Mar 31, 2025 | 158,442.00 |
| Mar 31, 2025 | 158,442.00 |
| Dec 31, 2024 | 91,564.00 |
| Dec 31, 2024 | 91,564.00 |
| Sep 30, 2024 | 48,683.00 |
| Sep 30, 2024 | 48,683.00 |
| Jun 30, 2024 | 35,978.00 |
| Jun 30, 2024 | 35,978.00 |
| Mar 31, 2024 | 29,685.00 |
| Mar 31, 2024 | 29,685.00 |
| Dec 31, 2023 | 27,890.00 |
| Dec 31, 2023 | 27,890.00 |
| Sep 30, 2023 | 35,794.00 |
| Sep 30, 2023 | 35,794.00 |
| Jun 30, 2023 | 51,990.00 |
| Jun 30, 2023 | 51,990.00 |